Company Overview and News

 
Serabi Gold plc: Appointment of Chief Operating Officer

2018-09-20 globenewswire
Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian-focused gold mining and development company, is pleased to announce the appointment of Mr. Roney Almeida, to the newly established position of Chief Operating Officer. Mr. Almeida, a Brazilian national and resident in Belo Horizonte, Brazil, will report to Mr. Mike Hodgson, CEO of Serabi Gold plc.
SBI SRBIF SRBID AAUKF AAL SRB NGLOY

1
Dr. David Broughton Joins Group Ten Metals as Senior Technical Advisor

2018-09-19 globenewswire
VANCOUVER, British Columbia, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Group Ten Metals Inc. (TSX.V: PGE; OTC: PGEZF, FSE: 5D32) (the “Company” or “Group Ten”) announces the appointment of Dr. David Broughton Ph.D., P.Geo., as Senior Technical Advisor, with a primary focus on the Company’s flagship Stillwater West PGE-Ni-Cu project in Montana, USA.
IVPAF DCGCF PGE PGEZF AAUKF NCPCF IVN AAL SWC NGLOY

 
Anglo American, QMEA to run trades camp for Queensland high schoolers

2018-09-18 australianmining.com.au
Several Year 11 and 12 students from Biloela and Moura in Queensland are to take part this week in an immersive trade careers camp set up by Anglo American and the Queensland Minerals and Energy Academy (QMEA), a partnership between the Queensland Government and Queensland Resources Council (QRC).
AAUKF AAL NGLOY

 
Q-Gold Announces Results of Annual and Special Meeting and Corporate Update

2018-09-14 globenewswire
VANCOUVER, British Columbia, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Q-Gold Resources Ltd. (the "Company") (TSX VENTURE: QGR) (http://www.qgoldresources.com) is pleased to announce that at the Annual and Special Meeting of shareholders (the “Meeting”) held on September 13, 2018, 100% of the shares at the Meeting voted for the re-election of Messrs. Fred Leigh and Robert C. Bryce as directors for the ensuing year and for the election of Mr.
CNR AAUKF AAL QGLDF NGLOY

3
Chilean lawmakers study extra tax for copper, lithium mines

2018-09-14 reuters
Sept 14 (Reuters) - Chile’s congress is studying a proposal for an additional royalty payment for copper and lithium miners operating in the country to bolster the development of the regions around their deposits, according to a draft seen by Reuters.
BLT ALB ANTO BHPBF ANFGY AAL ANFGF BHP AAUKF BBL 70GD BHP BHPLF NGLOY

2
Sibanye-Stillwater: Value In PGM Provides Free Call Option On Gold Assets

2018-09-14 seekingalpha - 1
Sibanye-Stillwater has been hit hard by climbing AISC at its gold mines in South Africa, as well as worker deaths and a politically charged environment.
GFI.WI DRD MLDUR AAL JMPLF DRDGF SWC SBGL.WI AAUKF JMPLY GFI GFIOF NGLOY

 
Collahuasi copper mine in Chile to raise output 4 pct this year -VP

2018-09-13 reuters
LIMA, Sept 13 (Reuters) - The copper mine Collahuasi in Chile is expected to produce 545,000 tonnes of copper this year, 4 percent more than in 2017, its vice president of operations, Francisco Carvajal, told journalists on the sidelines of an event in Peru on Thursday.
AAUKF AAL NGLOY

2
Teck's copper project attracts interest before end-Sept deadline - sources

2018-09-13 reuters
LONDON/TORONTO, Sept 13 (Reuters) - Mining companies and commodities trading houses are expected to table first-round offers by a September 28 deadline for a stake in Teck Resources Ltd’s Quebrada Blanca copper mine expansion in northern Chile, two sources with knowledge of the matter said.
LUNMF FCX AAL LUNCF LUN ZIJMY TECK NSU AAUKF 2899 SSUMF TCKRF NGLOY ZIJMF

 
Is Diamond Demand Crumbling?

2018-09-11 wolfstreet
Anglo American’s De Beers, the world’s No.1 diamond miner by value, has just had the lowest sales for its seventh cycle since it began releasing data in 2016, as it let customers delay acquiring smaller stones for the first time.
AAUKF AAL NGLOY

 
Orion Minerals’ shares ride higher on initial high-grade nickel-copper hits at Rok Optel

2018-09-10 proactiveinvestors.com.au
Orion Minerals Ltd’s (ASX:ORN) (JSE:ORN) initial drilling has confirmed high-grade polymetallic sulphide mineralisation at the Rok Optel nickel-copper-cobalt-platinum target in the Areachap Belt, South Africa.
ORN AAUKF AAL NGLOY

 
Man-made diamonds have jewellery industry on edge as De Beers enters market

2018-09-08 nzherald.co.nz
De Beers hasn't even opened its first synthetic diamond store, but its looming entry into the market for man-made gems has already shaken the industry.
AAUKF AAL NGLOY

1
The Korsakoff Syndrome

2018-09-07 seekingalpha
"A nation that forgets its past can function no better than an individual with amnesia." - David McCullough, American historian
AAUKF TWX AAL TWC NGLOY

 
Peru minister proposes making tax benefit for miners permanent

2018-09-06 reuters
LIMA, Sept 6 (Reuters) - Peruvian Energy and Mines Minister Francisco Ismodes on Thursday proposed making a temporary tax benefit for mining companies part of the country’s permanent tax code in order to reduce investment uncertainty in the world’s No. 2 copper producer.
AAUKF FCX AAL NGLOY

 
Freeport-McMoRan: Buy The China Induced Weakness

2018-09-06 seekingalpha
Freeport-McMoRan (FCX) trades near the lows of the last year in the mid-$13 range. The stock generally trades based on the price of copper that recently hit a double bottom around $2.65/lb. The trade discussions with China set up a potential rally in the red metal and the stock of the copper miner.
AAUKF FCX AAL NGLOY

2
Srinivasan Venkatakrishnan: The unusual chartered accountant

2018-09-04 moneycontrol - 1
A chartered accountant is an unlikely candidate to be the chief executive of a diversified mining conglomerate like Vedanta Resources.
AULGF VED AAUKF AU AAL AGG NGLOY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 00B1XZS82